Show me a cheaper FDA cleared for clinical trial company, that just got funded for said trials, owns Several Dozen patented IPs, with thousands of lab hours with frankly very exciting progression of its IP.
At .80 we will be in mRNA/siRNA Clinical Phase I and still cheap per share.